Table 1

Baseline characteristics of study participants stratified according to severity of FEV1 impairment

Severity of impairment
Quintile 1
(n=561)
Quintile 2
(n=562)
Quintile 3
(n=561)
Quintile 4
(n=562)
Quintile 5 (n=562)p for trend
Continuous variables are shown as mean (SD) and dichotomous variables are shown as number (% of column totals) unless otherwise indicated.
*Geometric mean.
BMI=body mass index; FEV1=forced expiratory volume in 1 second; FVC=forced vital capacity; CRP=C reactive protein.
FEV1 (% predicted)70.8 (14.9)90.1 (2.6)98.0 (2.1)100.5 (2.4)118.5 (8.3)0.001
FEV1 (l)2.15 (0.82)2.95 (0.70)3.23 (0.77)3.46 (0.82)3.53 (1.01)0.001
FEV1/FVC (%)69.0 (14.3)78.5 (8.3)80.7 (7.8)82.3 (7.4)82.3 (7.0)0.001
Age (years)53.1 (19.8)42.8 (18.0)40.2 (17.9)39.7 (17.6)46.3 (21.2)0.001
BMI (kg/m2)22.5 (2.4)22.6 (2.2)22.6 (2.2)22.9 (2.2)22.9 (2.0)0.001
Weight (kg)63.4 (10.6)64.2 (10.063.9 (9.9)64.1 (10.0)63.1 (9.7)0.685
Males297 (52.9%)278 (49.5%)259 (46.2%)249 (44.3%)252 (44.8%)0.001
Whites433 (77.2%)422 (75.1%)423 (75.4%)426 (75.8%)381 (67.8%)0.002
Current smokers227 (40.4%)187 (33.3%)151 (26.9%)130 (23.1%)136 (24.2%)0.001
Never smokers213 (38.0%)275 (48.9%)301 (53.7%)324 (57.7%)321 (57.2%)0.001
Serum albumin (g/l)40.9 (3.4)41.6 (3.5)41.6 (3.6)41.9 (3.6)41.6 (3.5)0.001
Serum folate (nmol/l)15.4 (14.2)14.8 (14.7)15.6 (15.6)14.1 (12.3)15.8 (12.8)0.952
Total serum cholesterol (mmol/l)5.3 (1.1)5.1 (1.1)5.0 (1.1)5.0 (1.0)5.2 (1.1)0.154
CRP (mg/l)*3.072.702.562.532.520.001
Leucocytes (×103/μl)7.07 (2.41)6.64 (2.09)6.35 (1.96)6.34 (1.86)6.26 (1.97)0.001
Fibrinogen (g/l)3.23 (0.88)3.08 (0.86)3.03 (0.92)2.88 (0.82)2.94 (0.74)0.001
Triceps skinfold (mm)13.8 (6.6)14.7 (6.9)14.8 (6.6)14.3 (6.6)13.2 (6.1)0.068